Siemens Healthcare of Malvern, PA, will use its PETNet Solutions wholly owned subsidiary and its national network of 47 radiopharmacies to distribute F-18 sodium fluoride (F-18 NaF) free of charge to help alleviate the effects of the global molybdenum shortage.
Participants in this trial program will receive F-18 NaF for a nominal delivery fee between March 22 and April 9.
The U.S. Food and Drug Administration has approved F-18 NaF for detecting bone metastases, and the Centers for Medicare and Medicaid Services (CMS) has recently approved coverage of F-18 NaF PET and PET/CT imaging to identify bone metastasis of cancer under certain conditions.
Submission of NaF scan claims to other insurers is permitted only if its use covers NaF PET bone scans. As a condition of participation for the Siemens' offer, providers cannot charge patients for the NaF dose.
Related Reading
Siemens completes U.K. order, March 10, 2010
Siemens to supply F-18 NaF via PETNet, March 8, 2010
Siemens launches CAD service at ECR meeting, March 5, 2010
Siemens debuts new CT family at ECR, March 4, 2010
Siemens renews NextGen alliance, February 11, 2010
Copyright © 2010 AuntMinnie.com
